Pharmaceutical News

RSS

New weight loss drug may be an effective strategy for preventing or treating high blood pressure

The new weight loss medication tirzepatide significantly lowered the systolic blood pressure (the top number in a blood pressure reading) for nearly 500 adults with obesity who took the medication for about eight months, according to new research published today in Hypertension, an American Heart Association journal.

5 Feb 2024

Study: Most new prescription drugs sold first in the U.S.

Most new prescription drugs are sold first in the U.S. before they reach other nations, but ultimately important medications are sold across most wealthy nations within about a year of first sale, according to a new RAND report.

5 Feb 2024

Over 80% of semaglutide users achieve significant weight loss after 12 months, study finds

...

5 Feb 2024

What does the future hold for obesity medication development?

The safety, clinical implications, and challenges of obesity pharmacotherapies based on entero-pancreatic hormone- treatments.

5 Feb 2024

Breakthrough obesity treatments on the horizon, rivaling surgery's success

New obesity pharmacotherapies, including GLP-1 receptor agonists and combinations of entero-pancreatic hormones, show promise in achieving significant weight loss, potentially rivaling bariatric surgery's effectiveness.

4 Feb 2024

XBB.1.5 updated COVID vaccine booster offers 54% increased protection against symptomatic infection

Early estimates show the 2023-24 updated monovalent XBB.1.5 COVID-19 vaccine offers significant protection against symptomatic infection, with effectiveness varying by age and time since vaccination.

4 Feb 2024

Small-molecule A485 mobilizes white blood cells on demand

New study reveals a small molecule that can selectively mobilize white blood cells, offering potential treatments for diseases with abnormal leukocyte counts.

3 Feb 2024

RAND report: Insulin prices in the U.S. are substantially higher than in high-income nations

The gross price of insulin in the U.S. is more than nine times higher than in 33 high-income comparison nations, according to a new RAND report.

2 Feb 2024

Newer clot-buster may offer a safe, effective way to treat ischemic stroke in mobile stroke units

Compared with the standard clot-busting medication alteplase, the newer clot-buster tenecteplase may offer a safe, effective and simpler way to treat ischemic (clot-caused) stroke in mobile stroke units, according to real-world experiences detailed in a preliminary study to be presented at the American Stroke Association's International Stroke Conference 2024.

1 Feb 2024

Surge in syphilis cases leads some providers to ration penicillin

When Stephen Miller left his primary care practice to work in public health a little under two years ago, he said, he was shocked by how many cases of syphilis the clinic was treating.

1 Feb 2024

UH researcher aims to revolutionize treatment regimens for triple-negative breast cancer

A researcher at the University of Houston College of Pharmacy Drug Discovery Institute is working to revolutionize treatment regimens for triple-negative breast cancer (TNBC) by proving that nebivolol, an FDA-approved drug for high blood pressure, is effective in treating it.

31 Jan 2024

SGLT2 inhibitors linked to lower risk of kidney stones in patients with type 2 diabetes

Rates of kidney stones are on the rise in the United States and around the world. Type 2 diabetes is associated with increased risk of kidney stones, but some forms of treatment for this condition may also have the benefit of lowering risk of kidney stones.

31 Jan 2024

The FTC is attacking drugmakers’ ‘patent thickets’

Previous
1
...
7
8
9
10
11
12
13
...
1415
Next

Pharmaceutical News

New weight loss drug may be an effective strategy for preventing or treating high blood pressure

Study: Most new prescription drugs sold first in the U.S.

Over 80% of semaglutide users achieve significant weight loss after 12 months, study finds

What does the future hold for obesity medication development?

Breakthrough obesity treatments on the horizon, rivaling surgery's success

XBB.1.5 updated COVID vaccine booster offers 54% increased protection against symptomatic infection

Small-molecule A485 mobilizes white blood cells on demand

RAND report: Insulin prices in the U.S. are substantially higher than in high-income nations

Newer clot-buster may offer a safe, effective way to treat ischemic stroke in mobile stroke units

Surge in syphilis cases leads some providers to ration penicillin

UH researcher aims to revolutionize treatment regimens for triple-negative breast cancer

SGLT2 inhibitors linked to lower risk of kidney stones in patients with type 2 diabetes

The FTC is attacking drugmakers’ ‘patent thickets’

Ketamine therapy for mental health a ‘wild West’ for doctors and patients

Records show Publix opioid sales grew even as addiction crisis prompted other chains’ pullback

Puffed-up MOFs show improved performance as drug-delivery vehicles

Unbiased assessment of vamorolone for treating Duchenne muscular dystrophy

Study confirms safety of COVID-19 vaccination during pregnancy for infant neurodevelopment

Balancing efficacy and safety: The challenges of mRNA drugs and vaccines in modern medicine

Maternal COVID-19 vaccination equally benefits preterm and full-term babies

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News